NNI-362

N/A

Report date: 2025/05/14 16:47:14
NME

Base Information

Drug NameNNI-362
Drug Alias NameNNI-362
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action70-kDa ribosomal protein S6 kinases stimulants
Targets70-kDa ribosomal protein S6 kinases
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseHodgkin Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeuronascent Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuronascent Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson DiseaseHodgkin Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A